| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |